Ketoprofen for agnosia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Dec 2024: Trial registered, NCT06731647
  2. 1 Feb 2025: Trial started, NCT06731647

The trials

NCT06731647: Non-steroidal Anti-inflammatory Drugs in Pleurodesis

State
Under way
Phase
Phase 2
People
358 planned
Started
1 Feb 2025
Primary completion
Nov 2027
Arms
Interventional group
Results
None posted
  1. 12 Dec 2024: Trial registered
  2. 1 Feb 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Actron, Actron ketoprofen, Alrheumat, Aneol, Capisten, Iso-k, KETOPROFEN(RP19583), Ketorin, Nexcede, Orudis, Oruvail, Sector.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.